» Articles » PMID: 35724271

Workflow for High-dimensional Flow Cytometry Analysis of T Cells from Tumor Metastases

Abstract

We describe a multi-step high-dimensional (HD) flow cytometry workflow for the deep phenotypic characterization of T cells infiltrating metastatic tumor lesions in the liver, particularly derived from colorectal cancer (CRC-LM). First, we applied a novel flow cytometer setting approach based on single positive cells rather than fluorescent beads, resulting in optimal sensitivity when compared with previously published protocols. Second, we set up a 26-color based antibody panel designed to assess the functional state of both conventional T-cell subsets and unconventional invariant natural killer T, mucosal associated invariant T, and gamma delta T (γδT)-cell populations, which are abundant in the liver. Third, the dissociation of the CRC-LM samples was accurately tuned to preserve both the viability and antigenic integrity of the stained cells. This combined procedure permitted the optimal capturing of the phenotypic complexity of T cells infiltrating CRC-LM. Hence, this study provides a robust tool for high-dimensional flow cytometry analysis of complex T-cell populations, which could be adapted to characterize other relevant pathological tissues.

Citing Articles

The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.

Noviello M, De Lorenzo R, Chimienti R, Maugeri N, De Lalla C, Siracusano G Front Immunol. 2024; 15:1381091.

PMID: 39136010 PMC: 11317765. DOI: 10.3389/fimmu.2024.1381091.


Highly purified and functionally stable expanded allospecific Tr1 cells expressing immunosuppressive graft-homing receptors as new candidates for cell therapy in solid organ transplantation.

Arteaga-Cruz S, Cortes-Hernandez A, Alvarez-Salazar E, Rosas-Cortina K, Aguilera-Sandoval C, Morales-Buenrostro L Front Immunol. 2023; 14:1062456.

PMID: 36911743 PMC: 9998667. DOI: 10.3389/fimmu.2023.1062456.

References
1.
Vitale I, Shema E, Loi S, Galluzzi L . Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat Med. 2021; 27(2):212-224. DOI: 10.1038/s41591-021-01233-9. View

2.
Kim H, Jeong S, Park S, Lee Y, Ju Y, Kim D . Implication of CD69 CD103 tissue-resident-like CD8 T cells as a potential immunotherapeutic target for cholangiocarcinoma. Liver Int. 2021; 41(4):764-776. DOI: 10.1111/liv.14814. View

3.
Godfrey D, Stankovic S, Baxter A . Raising the NKT cell family. Nat Immunol. 2010; 11(3):197-206. DOI: 10.1038/ni.1841. View

4.
Suzuki T, Hayman L, Kilbey A, Edwards J, Coffelt S . Gut γδ T cells as guardians, disruptors, and instigators of cancer. Immunol Rev. 2020; 298(1):198-217. DOI: 10.1111/imr.12916. View

5.
Ohue Y, Nishikawa H . Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?. Cancer Sci. 2019; 110(7):2080-2089. PMC: 6609813. DOI: 10.1111/cas.14069. View